Post-Transplantation Lymphoproliferative Disorders Solid-organ and hematopoietic stem-
cell transplants are widely used for various life-threatening medical disorders. Prophylaxis …

Infections remain a common complication of solid-organ transplantation. Most infections in
the first month after transplant are typically health care–associated infections, whereas late …

These updated guidelines from the American Society of Transplantation Infectious Diseases
Community of Practice review the diagnosis, management, and prevention of post …

Transplant recipients are vulnerable to a higher risk of malignancy after solid organ
transplantation and allogeneic hematopoietic stem-cell transplant. Post-transplant …

Posttransplant lymphoproliferative disorder (PTLD) is one of the most feared complications
following kidney transplantation. Over a 10-year period, the risk of PTLD in kidney transplant …

A higher risk for a variety of cancers is among the major complications of posttransplantation
immunosuppression. In this part of a continuing series on cancers posttransplantation, this …

COI notes: SI: Research Grant and Consultant-Seattle Genetics, Rhizen, Daiichi Sankyo,
Trillium; Research Grant-Merck, Affimed, Spectrum. SSN served as Advisory Board member …

A high intrapatient variability (IPV) in tacrolimus exposure is a risk factor for poor long‐term
outcomes after kidney transplantation. The main objective of this trial was to investigate …

Kidney transplant recipients (KTRs) have increased incidence of de novo cancers. After
having undergone treatment for cancer with curative intent, reducing the overall …

Organ transplantation has provided another chance of survival for end-stage organ failure
patients. Yet, transplant rejection is still a main challenging factor. Immunosuppressive drugs …